Condition: Progressive Pulmonary Fibrosis · Interstitial Lung Disease · Sponsor: University of Massachusetts, Worcester
This is a prospective, observational cohort study. Participants with non-idiopatic pulmonary fibrosis, interstitial lung disease (ILD) will be followed for 24 months to systematically collect clinical, imaging, and biospecimen data. The primary objective is to optimize progressive pulmonary fibrosis (PPF) classification and establish PPF incidence for key ILD subtypes. Additional exploratory objectives are to 1) Prospectively validate a novel PPF classifier and assess performance durability over time, and 2) Determine whether multi-dimensional PPF prediction outperforms component approaches.
This description comes directly from the study's public registry record.
Fernando J Martinez, MD, MS · 508-334-8685 · fernando.martinez1@umassmed.edu
Elizabeth Peters, BSN · 774-455-4432 · elizabeth.peters2@umassmed.edu
Always discuss trial participation with your own doctor first.
| University of Massachusetts Chan Medical School | Worcester, Massachusetts, United States | Recruiting |
| University of Michigan | Ann Arbor, Michigan, United States | Recruiting |
| University of Texas Southwestern | Dallas, Texas, United States | Not Yet Recruiting |
| University of Virginia | Charlottesville, Virginia, United States | Not Yet Recruiting |
| University of Washington | Seattle, Washington, United States | Not Yet Recruiting |
| Royal Prince Alfred Hospital | Camperdown, New South Wales, Australia | Not Yet Recruiting |
| Prince Charles Hospital | Brisbane, Queensland, Australia | Not Yet Recruiting |
| Austin Health | Melbourne, Victoria, Australia | Not Yet Recruiting |
| University of Calgary | Calgary, Alberta, Canada | Not Yet Recruiting |
| University of British Columbia | Vancouver, British Columbia, Canada | Not Yet Recruiting |
| University College Dublin | Dublin, Ireland, Ireland | Not Yet Recruiting |
| Royal Brompton | London, Greater London, United Kingdom | Not Yet Recruiting |
+ 1 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06855329